Skip to content

DR INGE VAN HAUTE

Active
Private limited companyfounded 2010active for 16 yearsRigaudrye 13, 7890 Ellezelles, BelgiumKBO/BCE: BE 0825.964.007
Summary

DR INGE VAN HAUTE has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €2.2m and a net result of €342,803. Equity is growing by about 24% per year across the filed financial years. Its solvency ranks better than 64% of 19,950 sector peers (NACE 86, financial year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
#1 company by equity in Ellezelles1 site
Size
€2.8mtotal assets 2024
Equity
€2.2m
Profit
€342,803
Turnover not published (micro format)
Financial health
56 Fair Checked score 2024
Bankruptcy probabilitywithin 12 months
0.2%
Structure
Accounts 70 days overdue0 of 2 deeds read
Why 56raises riskCapped at 59: a confirmed filing finding1 financial year not filed after the legal deadline; latest accounts 92 days late; 3 of the last 3 lateFigures for financial year 2024 (filed 31-10-2025)lowers riskSector: Human health activities (NACE 86)Founded in 2010Show the evidence

Checked score

Score 2024
56 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 57% of its sector peers (NACE 86, small)
A confirmed filing finding caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick = 2023
Strong
Solvency 100=
equity 78.4% of total assets
Liquidity 60+2
short-term debt 15.2% · cash 10.7%
Profitability 84+1
return on assets 12.4%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,072 companies, NACE 86, small)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.2%▲ +0.1 percentage points vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025highest value 11-2025: < 0.1%▼ -0.2 percentage points vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: 0.1%▲ +0.1 percentage points vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.2%▲ +0.1 percentage points vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026
Credit of up to €120,000 on 30-day terms, only on tighter conditions
Liquidity ample (current ratio 5.75, compared with 5.78 in 2023; short-term debt: 15.2% and cash: 10.7% of total assets), and 21.6% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small): better than 77% on solvency, 45% on liquidity, 61% on profitability and 43% on growth.

The bankruptcy probability was computed on 08-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk+raises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · 1 financial year not filed after the legal deadline; latest accounts 92 days late; 3 of the last 3 late
NBB · filings
raises risk · Figures for financial year 2024 (filed 31-10-2025)
NBB · annual accounts
lowers risk · Founded in 2010
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
raises risk · Filed more than 90 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 31-10-2025, 92 days past the deadline. Measured on financial year 2023: of the companies more than 90 days late, 5.61% are now in a legal situation other than normal in the KBO (such as bankruptcy, liquidation or dissolution), against 1.66% of all filers.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
92 days late
2023
89 days late
2022
66 days late
2021
30 days late
2020
90 days late
2019
91 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 76 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2024 · micro…
  2. Annual accounts filedfinancial year 2023 · micro…
  3. Equity above €2mequity €2.0m ▲8.7%

Key points

  • Positive: Company by equity in Ellezellesin the Checked rankings #1 View
  • Caution: Accounts not fileddeadline was 31-07-2026 70 days late View
  • Positive: 7 profitable years in a rowprofit 2024: €342,803 7 years View

By topic

Financials

Financial year
2024
Total assets
€2.8m
Profit
€342,803
Solvency
78.4%
Total assets▲ 4.8%
Net result
20182024
Go to Financials

Timeline

Events
18
Since
2012
  1. 05-10-2023Annual accounts filed
  2. 31-12-2022Highest result from 2018 to 2024
  3. 30-08-2022Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
18-05-2010
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.